Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
Conditions
- Severe Aortic Stenosis
- Transcatheter Aortic Valve Replacement
- Aortic Valve Replacement
Interventions
- DRUG: Bivalirudin
- DRUG: Unfractionated Heparin
Sponsor
The Medicines Company